3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Acrocephalosyndactylia
5
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Stomach Neoplasms
1
Recurrence
1
Oligodendroglioma
1
Neoplasms, Unknown Primary
1
Multiple Myeloma
1
Lung Neoplasms
1
Glioma
1
Glioblastoma
1
Eosinophilia
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Advanced Malignancies
1
Interventions
Mitomycin
9
Gemcitabine
5
apaziquone
3
Docetaxel
2
valrubicin
1
pembrolizumab
1
linrodostat
1
erdafitinib
1
enzalutamide
1
avelumab
1
VB4-845
1
Standard of Care
1
Nivolumab
1
Neoadjuvant Therapy
1
Hyaluronic Acid
1
DDMS
1
BCG Vaccine
1
Administration, Intravesical
1
ALT-801
1
5-aminolevulinic acid hexyl ester
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Non-Muscle Invasive Bladder Neoplasms
×
pemigatinib
×
Clear all
No trials found.